Carrick Therapeutics
Christopher Tapper serves as a Board Observer for Carrick Therapeutics, Epitopea, Microbiotica, and Exvastat. In addition to these roles, Christopher Tapper holds the position of Senior Investment Associate and previously served as an Investment Associate at Cambridge Innovation Capital.
This person is not in the org chart
This person is not in any offices